aldafermin
aldafermin: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) | Phase 2/Phase 3 |
Clinical Trials (1)
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of Aldafermin in Subjects With Primary Sclerosing Cholangitis (ALPINE-PSC).
Frequently asked questions
Who is developing aldafermin?
aldafermin is being developed by NGM BIOPHARMACEUTICALS INC.
How many clinical trials involve aldafermin?
BioSniper tracks 1 clinical trial involving aldafermin.
Get deeper analysis on aldafermin
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis